Cargando…
Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
BACKGROUND: The difference in restricted mean survival time ([Formula: see text] ), the area between two survival curves up to time horizon [Formula: see text] , is often used in cost-effectiveness analyses to estimate the treatment effect in randomized controlled trials. A challenge in individual p...
Autores principales: | Lueza, Béranger, Rotolo, Federico, Bonastre, Julia, Pignon, Jean-Pierre, Michiels, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812643/ https://www.ncbi.nlm.nih.gov/pubmed/27025706 http://dx.doi.org/10.1186/s12874-016-0137-z |
Ejemplares similares
-
Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
por: Lueza, Béranger, et al.
Publicado: (2016) -
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study
por: Lueza, Béranger, et al.
Publicado: (2016) -
Individual patient data network meta-analysis using either restricted mean survival time difference or hazard ratios: is there a difference? A case study on locoregionally advanced nasopharyngeal carcinomas
por: Petit, C., et al.
Publicado: (2019) -
Extrapolation of Survival Curves from Cancer Trials Using External Information
por: Guyot, Patricia, et al.
Publicado: (2016) -
Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials
por: Ternès, Nils, et al.
Publicado: (2017)